ClinicalTrials.Veeva

Menu

Predicting Vaccine Hesitancy Using Machine Learning

U

University of Yalova

Status

Active, not recruiting

Conditions

Vaccine Refusal
Machine Learning
Vaccine Hesitancy
Children

Study type

Observational

Funder types

Other

Identifiers

NCT06988969
Emel Avcin MLT

Details and patient eligibility

About

In recent years, emerging technologies such as the Internet of Things (IoT), Artificial Intelligence (AI), and Virtual Reality (VR) have rapidly become integrated into daily life. The widespread use of these applications has led to the accumulation of vast amounts of data, giving rise to what is commonly referred to as "Big Data." Due to the sheer volume, manual processing and analysis of these large datasets are not feasible. Therefore, software tools and libraries-such as Python and R libraries-have been developed to perform these analyses efficiently and to generate predictions for the future by leveraging historical data through Machine Learning (ML) algorithms.

The primary goal of machine learning algorithms is to discover patterns within existing data and use these patterns to make accurate predictions on new data. The use of machine learning in the field of healthcare has gained significant momentum in recent years. However, a review of the literature reveals that research specifically addressing childhood vaccine hesitancy remains limited.

This study aims to identify the factors contributing to vaccine hesitancy among parents of children aged 0-48 months and to develop a predictive model using machine learning techniques based on these factors. Such a model could help anticipate the likelihood of vaccine refusal among parents and thereby support the development of targeted public health strategies for at-risk populations.

Enrollment

600 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Parents who meet the following criteria will be included in the study:

  • Have proficiency in understanding and reading the Turkish language,
  • Are able to use technological devices such as mobile phones or computers to access social media platforms (Participants used social media platforms such as Instagram and WhatsApp to communicate) via the internet,
  • Are 18 years of age or older,
  • Have children aged 0-4 years,
  • Consent to participate in the study,
  • Have children without any absolute contraindications to vaccination.

Exclusion criteria

  • Parents of high-risk infants (such as those with a history of systemic illness, preterm labor, anomalies, etc.),
  • Parents who are unwilling to participate in the study will be excluded.

Trial design

600 participants in 1 patient group

Parents of children aged 0-48 months
Description:
Parents who meet the following criteria will be included in the study: those who have proficiency in understanding and reading the Turkish language; are 18 years of age or older; have children aged 0-4 years; are able to use technological devices such as mobile phones or computers to access social media platforms (Participants used social media platforms such as Instagram and WhatsApp to communicate) via the internet; consent to participate in the study; and whose children do not have any absolute contraindications for vaccination.

Trial contacts and locations

1

Loading...

Central trial contact

ŞEYDA CAN, Ass Prof; EMEL AVÇİN, Assist Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems